NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The new prime minister has promised to focus more on Canadian-built defense products and shift spending away from the purchases of U.S.-built equipment.Read More